ASXL1 mutation-related clonal hematopoiesis and age-related diseases: clinical evidence and molecular insights

Abstract excerpt

Clonal hematopoiesis (CH) is defined as the age-associated expansion of hematopoietic stem and progenitor cells harboring somatic mutations, most frequently in epigenetic regulators such as DNMT3A, TET2, and ASXL1. Although CH was initially recognized as a precursor to hematological malignancies, accumulating evidence has led to its broad recognition as a relevant factor in various age-related nonmalignant...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Acute Myeloid Leukemia Research
• Share to Immunodeficiency and Autoimmune Disorders
• Share to Myeloproliferative Neoplasms: Diagnosis and Treatment